Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re Offer for Subscription

8 Feb 2021 09:56

RNS Number : 3062O
Maven Income & Growth VCT PLC
08 February 2021
 

Maven Income and Growth VCT PLC (the Company)

 

Offer for Subscription

 

8 February 2021

 

On 23 October 2020, the Company and Maven Income and Growth VCT 5 PLC announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription of new Ordinary Shares of 10p each (together the "Offers" and each an "Offer").

 

The Board is pleased to advise that, with valid subscriptions received to date under the Company's Offer now approaching its initial fundraising target of £10 million, and in view of continued interest from potential investors, the Directors have resolved to utilise the over-allotment facility, as provided for under the terms and conditions of the Offers, to the extent required to meet further investor demand.

 

The deadline for receipt of applications for the Offers is 12.00 noon on 30 March 2021 in relation to the tax year 2020/21 and 12.00 noon on 30 April 2021 in relation to the tax year 2021/22. The Offers will close on 4 May 2021 unless the relevant Offer is fully subscribed by an earlier date or extended by the relevant Board to no later than 6 October 2021.

 

Downloadable versions of the Prospectus documents are available at: www.mavencp.com/vctoffer.

 

Any enquiries in respect of the Offers, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com 

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKVLBBFLLEBBX
Date   Source Headline
28th Jan 202511:27 amRNSDirector/PDMR Shareholding
28th Jan 202511:25 amRNSDirector/PDMR Shareholding
28th Jan 202510:39 amRNSIssue of Equity
24th Jan 202511:32 amRNSNet Asset Value(s)
29th Nov 20249:33 amRNSIssue of Equity - Dividend Investment Scheme
26th Nov 20243:51 pmRNSStatement re Dividend Investment Scheme
14th Nov 20242:51 pmRNSResult of General Meeting
24th Oct 20247:00 amRNSHalf-year Report
17th Oct 20244:27 pmRNSTransaction in Own Shares
16th Oct 20244:59 pmRNSTransaction in Own Shares
14th Oct 20243:25 pmRNSUnaudited Net Asset Value and Interim Dividend
27th Sep 20244:31 pmRNSPublication of a Prospectus
5th Sep 20244:45 pmRNSUnaudited Net Asset Value
19th Jul 20242:25 pmRNSIssue of Equity - Dividend Investment Scheme
18th Jul 20244:16 pmRNSTransaction in Own Shares
17th Jul 20245:03 pmRNSTransaction in Own Shares
15th Jul 20243:07 pmRNSStatement re Dividend Investment Scheme
15th Jul 20242:23 pmRNSStatement re Dividend Investment Scheme
12th Jul 20242:56 pmRNSNet Asset Value(s)
11th Jul 20241:38 pmRNSResult of AGM
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
31st May 20244:16 pmRNSFinal Results
16th May 20243:13 pmRNSTransaction in Own Shares
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.